Guidance

Antipsychotic medicines: licensed products, uses and side effects

Antipsychotic drugs available in the UK, their side effects and their effect on dementia patients.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 25 August 2005

Documents

Antipsychotic medicines

HTML

Pharmacovigilance Working Party Public Assessment Report on neuroleptics and cardiac safety

PDF, 38 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Pharmacovigilance Working Party Public Assessment Report on antipsychotics and cerebrovascular accident

PDF, 84 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This guidance explains how antipsychotics work and the antipsychotics that are licensed for use in the UK. It also examines some main side effects of this type of medicine and including risks associated with the use of antipsychotics in elderly people with dementia.

Published 25 August 2005